平喘养肺汤联合布地奈德治疗COPD稳定期患者的疗效与安全性研究(4)
[9]Maleki-Yazdi MR，Beck E，Hamilton AL，et al.A randomised，placebo-controlled，Phase II，dose-ranging trial of once-daily treatment with olodaterol，a novel long-acting β2-agonist，for 4 weeks in patients with chronic obstructive pulmonary disease[J].Respir Med ......
您现在查看是摘要页，全文长 1931 字符。